Description
The HOYA Vivinex iSert XY1 is an advanced intraocular lens (IOL) system specifically designed for cataract surgery. This preloaded lens system offers a range of features aimed at enhancing visual outcomes and surgical ease.
Material and Design
Crafted from glistening-free hydrophobic acrylic, the lens includes UV and blue light filters, providing protection and clarity. Its proprietary aspheric optic design, with biconvex and aspheric anterior surfaces, is engineered to reduce spherical aberration and minimize coma, even with decentration. This monofocal lens aims to deliver high-quality, clear vision.
Edge and Haptic Features
The lens features a square, thin, and textured optic edge with an edge radius of less than 10.0μm. The textured-rough haptic surface enhances grip and reduces adhesion, contributing to stable positioning within the eye. Active oxygen processing ensures a smooth surface, designed to lower the risk of posterior capsule opacification (PCO) and dysphotopsia.
Dimensions and Power Range
With an optic diameter of 6.00 mm and an overall length of 13.00 mm, the lens is available in a power range from +6.00 to +30.00 diopters, in 0.50 D increments. This allows for precise customization to meet individual patient needs.
Injector System
The Vivinex iSert XY1 comes with a preloaded injector system, featuring a front injector tip outer diameter of 1.70 mm. It is recommended for incision sizes of 2.20 mm, facilitating minimally invasive surgical techniques.
Clinical Performance
Clinical studies highlight the lens's glistening-free quality and significantly lower PCO and Nd:YAG capsulotomy rates compared to other lenses. It demonstrates high refractive predictability, with a substantial percentage of outcomes closely matching target refraction.
Handling and Safety
Designed for healthcare professionals, the lens is preloaded for straightforward implantation into the capsular bag. It is MRI safe at 1.5 and 3.0 Tesla, ensuring compatibility with common imaging technologies. The HOYA Vivinex iSert XY1 is intended to provide long-term biocompatibility and clarity of vision, making it a reliable choice for cataract surgery.
